Marjorie E. Koenen

Marjorie E. Koenen

Auto-generated profile, based on publicly available information

Marjorie E. Koenen

Earth, Environmental and Life Sciences, Netherlands Organization for Applied Scientific Research (TNO), Zeist, The Netherlands

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in British Poultry Science
Verified
Journal Article
Closed access
MKM.E. Koenen
M.E. Koenen
JKJ. Kramer
J. Kramer
RHR. van der Hulst
R. van der Hulst
LHL. Heres
L. Heres
SJS.H.M. Jeurissen
S.H.M. Jeurissen
WBW.J.A. Boersma
W.J.A. Boersma
1. The aim of the experiments was to evaluate whether selected probiotic lactobacillus strains have different immunomodulating effects in layer- and meat-type strain chickens. 2. Humoral and cellular specific and non-specific immune responses were studied by experiments on cellular proliferation, entry and survival of Salmonella bacteria in gut and spleen leukocytes, immunoglobulin isotypes and specific immunoglobulin titres. 3. The effects of two different feeding regimes (short and continuous feeding) and doses for administration of lactobacilli were studied. 4. The lactobacillus strains that were evaluated showed modulating effects on the immune system of layer- and meat-type chickens. 5. In meat-type strain chickens the lactobacilli had a stimulating effect when the chickens were young (up to 3 weeks) and the dose was relatively high, whereas in layer-type chickens a lower effective dose and discontinuous administration was also effective. 6. Immunoprobiotic lactobacilli can have a positive effect on humoral and cellular immune responses in layer- and meat-type strain chickens, but the lactobacillus strain to be used, the age of the animals and effective dose of lactobacilli to be administered need to be optimised.

1 December 2014 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
KVKoen Venema
Koen Venema
JRJavier Ramiro-Garcia
Javier Ramiro-Garcia
MKMarjorie E. Koenen
Marjorie E. Koenen
KVKoen Venema
Koen Venema

1 October 2002 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
MKMarjorie E Koenen
Marjorie E Koenen
ABAnneke G Boonstra-Blom
Anneke G Boonstra-Blom
SJSuzan H.M Jeurissen
Suzan H.M Jeurissen

3 August 2009 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
MAMaaike M. Appeldoorn
Maaike M. Appeldoorn
DVDini P. Venema
Dini P. Venema
TPTheodorus H. F. Peters
Theodorus H. F. Peters
MKMarjorie E. Koenen
Marjorie E. Koenen
IAIlja C. W. Arts
Ilja C. W. Arts
PHPeter C. H. Hollman
Peter C. H. Hollman

1 October 2015 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
KVKoen Venema
Koen Venema
AEAnat Eck
Anat Eck
MKMarjorie E. Koenen
Marjorie E. Koenen
PSPaul H.M. Savelkoul
Paul H.M. Savelkoul
ABAndries E. Budding
Andries E. Budding
KVKoen Venema
Koen Venema

27 March 2012 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
ARAteequr Rehman
Ateequr Rehman
FHFemke-Anouska Heinsen
Femke-Anouska Heinsen
MKMarjorie E Koenen
Marjorie E Koenen
KVKoen Venema
Koen Venema
HKHenrik Knecht
Henrik Knecht
SOStephan J Ott
Stephan J Ott
Background: Antibiotic associated diarrhea and Clostridium difficile infection are frequent complications of broad spectrum antibiotic therapy. Probiotic bacteria are used as therapeutic and preventive agents in these disorders, but the exact functional mechanisms and the mode of action are poorly understood. The effects of clindamycin and the probiotic mixture VSL#3 (containing the 8 bacterial strains Streptococcus thermophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus delbrueckii subsp. Bulgaricus) consecutively or in combination were investigated and compared to controls without therapy using a standardized human fecal microbiota in a computer-controlled in vitro model of large intestine. Microbial metabolites (short chain fatty acids, lactate, branched chain fatty acids, and ammonia) and the intestinal microbiota were analyzed. Results: Compared to controls and combination therapy, short chain fatty acids and lactate, but also ammonia and branched chain fatty acids, were increased under probiotic therapy. The metabolic pattern under combined therapy with antibiotics and probiotics had the most beneficial and consistent effect on intestinal metabolic profiles. The intestinal microbiota showed a decrease in several indigenous bacterial groups under antibiotic therapy, there was no significant recovery of these groups when the antibiotic therapy was followed by administration of probiotics. Simultaneous application of anti- and probiotics had a stabilizing effect on the intestinal microbiota with increased bifidobacteria and lactobacilli. Conclusions: Administration of VSL#3 parallel with the clindamycin therapy had a beneficial and stabilizing effect on the intestinal metabolic homeostasis by decreasing toxic metabolites and protecting the endogenic microbiota from destruction. Probiotics could be a reasonable strategy in prevention of antibiotic associated disturbances of the intestinal homeostasis and disorders.